Download PDF

Other users also viewed these articles

Antibiotic discontinuation through an antibiotic treatment optimization program in emergency department patients with low suspicion of infection Paula Martínez-de la Cruz; Leonor Moreno-Núñez; Sara Álvarez-Atienza; Sira Sanz-Márquez; José Francisco Valverde-Canovas; Juan Emilio Losa-García;
Enferm Infecc Microbiol Clin. 2023;41:423-5
Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;
Enferm Infecc Microbiol Clin. 2025;43:86-92
Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years Alejandro Salinas-Botrán; Carmen Olmos-Blanco; David Fernández de Velasco-Pérez; Alicia Guzmán-Carreras; Alejandro Morales-Rosas; Daniel Gómez-Ramírez;
Enferm Infecc Microbiol Clin. 2025;43:71-9